NCT00408382View on ClinicalTrials.gov

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Conditions
HypercholesteremiaCoronary Artery Disease
Interventions
DRUG

atorvastatin, Lipitor

Trial Locations (2)

Unknown

Osaka

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00408382 - Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque | Biotech Hunter | Biotech Hunter